CNBC Stock Blog
- Why You Should Play the Reflation Trade: Stock Picker
- S&P to Hit 1,200 by Year-End: Chief Investor
- 5 Big Bank Stocks Investors Should Consider: Strategists
- My 2010 Home Price Outlook: UBS Analyst
- Why Are Options Piling into Dollar Tree?
- Markets Can Rise 5-10% in the Near-Term: Strategist
- Buy These 'Competitively Positioned' Stocks: Portfolio Manager
- 5 Stocks That Benefit from Health Care Legislation: Analysts
- 9 Stocks That Play Rising Water Costs: Strategists
- Gold Prices Can Double in 3 Years: Portfolio Manager
MOST SHARED
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Citi Mortgage Reveals What Treasury Won't
- NBA D-League On The Rise
- Wednesday's Economic News Crunch Could Tilt Markets
- Japan Export Rebound Eases Fear of New Recession
- Australia Wheat Exporters Face Challenges: GrainCorp
- Trading Block
- Confessions of a Black Friday Shopper
- The Social Media Gaming Threat
- Citi Mortgage Reveals What Treasury Won't
- S&P to Hit 1,200 by Year-End: Chief Investor
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- Facebook's Biggest-Ever Holiday Shopping Season
- Facebook's New Dual Class Structure - Slow Steps to an IPO
- 5 Big Bank Stocks Investors Should Consider: Strategists
- Gambling Drunk, Texting to Live And America's On Sale - Your Emails
- Nov. 24: Unusual Volume Leaders
- NBA D-League On The Rise
- Wednesday's Economic News Crunch Could Tilt Markets
- Call Me Crazy: Confessions of a Black Friday Shopper
- US Firms Hit by Payroll Taxes at Exactly the Wrong Time
- Citi Mortgage Reveals Something the US Treasury Won't
- Fed Sanguine About US Recovery, Worried on Jobs
- Amended Berkshire Filing Reveals No 'Secret' Holdings
- In Time for Holidays: More Gloom and Doom on Economy
- Holiday Guide to This Season's Smartphones
- Market Pros Reveal Top Black Friday Trades
RSS FEED
Text Size 
Special to CNBC.com
Health-care and pharmaceutical stocks are facing a great amount of uncertainty in the wake of health-care reform. Rosanne Ott, co-portfolio manager at Alger Health Sciences Fund, offered CNBC her investment advice and favorite stocks.
Investors should look for stocks that are growing their revenues faster than Wall Street expected; that are introducing a new product cycle; and are either a monopoly or oligopoly that will grow its units faster than its competitors, said Ott.
"I think everything's going to be affected in some way, shape or form, but it's a matter of what's going to have the least amount of effect" from reform efforts, Ott said.
Ott Likes:
NuVasive [NUVA
Loading...
()
] — a spine technology company. It has created a product that allows surgeons to perform more procedures in one day.
Life Technologies [LIFE
Loading...
()
] — a biotechnology tools company she said will benefit from stimulus spending in the next 12 to 18 months.
Intuitive Surgical [ISRG
Loading...
()
] — a monopoly in surgical robotics, Ott said.
"It's growing its revenues faster than people anticipate even in the environment of health-care reform, where hospitals have very tight capital equipment budgets."
______________________________
CNBC Data Pages:
______________________________
CNBC Slideshows:
___________________________
______________________________
CNBC's Companies in the News:
______________________________
Disclosures:
Disclosure information was not available for Ott or her company.
Data is a real-time snapshot *Data is delayed at least 15 minutes